Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
APOPW was delisted on the 3rd of August, 2021.
1 hedge funds and large institutions have $60K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
43% more capital invested
Capital invested by funds: $42K → $60K (+$18K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $60K | +$19.5K | +8,326 | +41% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$1K | -500 | Closed |
|
APOPW Hedge Fund Activity: Q4 2017 in Review
1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q4 2017, worth a combined $60K — up 43% from $42K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of APOPW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $19.5K. The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 1 institutional investor held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $60K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q4 2017, up 43% quarter-over-quarter.
- 0 funds opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs buyer in Q4 2017 was Susquehanna International Group, an estimated $19.5K added.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs seller in Q4 2017 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2017.